Literature DB >> 194838

Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.

A Moller-Larsen, I Heron, S Haahr.   

Abstract

Herpes simplex virus type 1 (HSV-1)-infected human skin fibroblasts were used as target cells in a 51Cr release assay, using peripheral blood mononuclear cells from HSV-seropositive and -seronegative donors as effector cells. Cytotoxicity was exerted by ordinarily prepared lymphoid cells but could be reduced by extensive washing of the effector cells. The antibody dependence of the system was shown by the recovery of activity through addition of positive serum or medium used for the early washes of effector cells. Three donors found to be seronegative in the usual serological tests were shown to be seropositive in this test. It is proposed that the assay can be used as a very sensitive serological test.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194838      PMCID: PMC421485          DOI: 10.1128/iai.16.1.43-47.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method.

Authors:  S B Greenberg; B S Criswell; R B Couch
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

2.  Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.

Authors:  B Härfast; T Andersson; P Perlmann
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

3.  Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.

Authors:  S L Shore; C M Black; F M Melewicz; P A Wood; A J Nahmias
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

4.  Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus.

Authors:  Y H Thong; S A Hensen; M M Vincent; D A Fuccillo; W A Stiles; J A Bellanti
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

5.  Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.

Authors:  Y H Thong; M M Vincent; S A Hensen; D A Fuccillo; M Rola-Pleszczynski; J A Bellanti
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

6.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

7.  Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.

Authors:  R W Steele; M M Vincent; S A Hensen; D A Fuccillo; I A Chapa; L Canales
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

8.  Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus.

Authors:  S L Shore; A J Nahmias; S E Starr; P A Wood; D E McFarlin
Journal:  Nature       Date:  1974-09-27       Impact factor: 49.962

9.  A 51 Cr microassay technique for cell-mediated immunity to viruses.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

10.  Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity.

Authors:  R Labowskie; R Edelman; R Rustigian; J A Bellanti
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

View more
  12 in total

1.  Aujeszky's disease vaccination and infection of pigs with maternal immunity: effects on cell- and antibody-mediated immunity.

Authors:  G Wittmann; V Ohlinger
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.

Authors:  N Balachandran; P Seth; L N Mohapatra
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

3.  Cell-mediated and humoral immune responses to herpes simplex virus and cytomegalovirus in renal transplant patients.

Authors:  S Haahr; A Møller-Larsen; H K Andersen; E S Spencer
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

4.  Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.

Authors:  C Ching; C Lopez
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

5.  Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus.

Authors:  A Møller-Larsen; S Haahr
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

6.  Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.

Authors:  S Kohl; D B Drath; L S Loo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis.

Authors:  A Møller-Larsen; S Haahr; F T Black
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

8.  Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.

Authors:  S Kohl; C M Moore
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

9.  Natural and immune cytolysis of canine distemper virus-infected target cells.

Authors:  W R Shek; R D Schultz; M J Appel
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.